Planet 13 Holdings Inc. (CSE: PLTH)
PLTH trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 16, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for PLTH.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").
Profile
| Field | Value |
|---|---|
| Ticker | PLTH on the Canadian Securities Exchange |
| Yahoo symbol | PLTH.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | The TMX list gives no head office |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 335,319,455 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001813452 |
| Website | www.planet13.com |
Returns
| Window | Return |
|---|---|
| 1 day | -7.7% |
| 1 week | +4.3% |
| 1 month | -20.0% |
| 3 months | -41.5% |
| 6 months | -38.5% |
| Year to date | -57.1% |
| 1 year | -50.0% |
| From 52-week high | -74.5% |
| 52-week range | C$0.1050 to C$0.4700 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
8 documents in 5 types. Each title links to the document at its source.
News release (1)
| Document | Type | Filed |
|---|---|---|
| Press Release dated November [ ], 2026. | News release (8-K) | 2026-11-12 |
Management information circular / proxy (1)
| Document | Type | Filed |
|---|---|---|
| DEFM14A | Proxy statement (DEFM14A) | 2026-11-02 |
Quarterly report (1)
| Document | Type | Filed |
|---|---|---|
| FORM 10-Q Period 2026-09-30 | Quarterly report (10-Q) (10-Q) | 2026-11-12 |
Certification (4)
| Document | Type | Filed |
|---|---|---|
| EXHIBIT 31.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EXHIBIT 31.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EXHIBIT 31.3 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
| EXHIBIT 32.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-12 |
Other (1)
| Document | Type | Filed |
|---|---|---|
| FORM 8-K | Current report (8-K) (8-K) | 2026-11-12 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-12-10 | No time in the announcement | Special meeting Shareholder meeting | No webcast link announced | SEC filing |
Recent
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-11-12 | No time in the announcement | Q3 2026 earnings release | No webcast link announced | SEC filing |
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2024-05-22 | Equity | US$54.4M | US$54.4M | SEC EDGAR |
| 2023-11-27 | Equity | US$710K | US$710K | SEC EDGAR |
| 2020-12-01 | Equity | US$2.5M | US$2.5M | SEC EDGAR |
| 2020-05-29 | Equity | US$4.0M | US$4.0M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on SEC CIK. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| LSL | LSL Pharma Group Inc. | TSXV | C$39.9M | +8.3% | -7.1% |
| SVA | Sernova Biotherapeutics Inc. | TSX | C$39.7M | 0.0% | -21.4% |
| MBX | Microbix Biosystems Inc. | TSX | C$40.9M | 0.0% | +11.1% |
| MRMD | MariMed Inc. | CSE | C$38.6M | +11.8% | -26.9% |
| MDNA | Medicenna Therapeutics Corp. | TSX | C$42.0M | -11.5% | -71.9% |
The app has the price chart, every filing, private raises and the full peer set for PLTH.
Open in the app